| scholarly article | Q13442814 |
| P50 | author | Daniel R. Neill | Q41681295 |
| Stephen B. Gordon | Q42703812 | ||
| Mathieu Bangert | Q47708130 | ||
| David Goldblatt | Q51053608 | ||
| Daniela M Ferreira | Q57005808 | ||
| Shaun H Pennington | Q58765120 | ||
| Eliane N Miyaji | Q58765151 | ||
| Aras Kadioglu | Q61609002 | ||
| P2093 | author name string | Jenna F Gritzfeld | |
| Adam K A Wright | |||
| Angela D Wright | |||
| Laura Bricio-Moreno | |||
| Andrea M Collins | |||
| Nicola Green | |||
| Adriana T Moreno | |||
| P2860 | cites work | Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children. | Q41827353 |
| Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model | Q42171376 | ||
| The immune response to pneumococcal proteins during experimental human carriage | Q42944608 | ||
| Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae. | Q43078345 | ||
| Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities | Q46898607 | ||
| Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. | Q53083052 | ||
| The current burden of pneumococcal disease in England and Wales | Q57385772 | ||
| Nasopharyngeal carriage with Streptococcus pneumoniae augments the immunizing effect of pneumolysin toxoid B | Q58043338 | ||
| Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis | Q59244201 | ||
| Lack of pneumococcal carriage in the hospitalised elderly | Q61911776 | ||
| Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules | Q73502898 | ||
| Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children | Q74332994 | ||
| Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades | Q80738099 | ||
| Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? | Q24809188 | ||
| Comparison of a new multiplex binding assay versus the enzyme-linked immunosorbent assay for measurement of serotype-specific pneumococcal capsular polysaccharide IgG | Q28392402 | ||
| Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation | Q28744146 | ||
| Interleukin-17A mediates acquired immunity to pneumococcal colonization | Q33370537 | ||
| Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection. | Q33725192 | ||
| Potential role for mucosally active vaccines against pneumococcal pneumonia | Q33792681 | ||
| Comparison between nasopharyngeal swab and nasal wash, using culture and PCR, in the detection of potential respiratory pathogens | Q33871573 | ||
| CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization | Q33935327 | ||
| Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. | Q33996628 | ||
| Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage | Q34229627 | ||
| Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells | Q35229917 | ||
| Streptococcus pneumoniae colonisation: the key to pneumococcal disease | Q35681330 | ||
| Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. | Q35784046 | ||
| Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes | Q35927343 | ||
| Epidemiological differences among pneumococcal serotypes | Q36024118 | ||
| Inflammation markers predicting frailty and mortality in the elderly. | Q36388062 | ||
| Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans | Q36658296 | ||
| Experimental human pneumococcal carriage. | Q36695032 | ||
| Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins | Q36898018 | ||
| The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease | Q37109940 | ||
| Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage | Q37213916 | ||
| Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice | Q37241352 | ||
| The pneumococcus: why a commensal misbehaves | Q37629673 | ||
| The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. | Q39910189 | ||
| Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization | Q39912979 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Streptococcus pneumoniae | Q221179 |
| P304 | page(s) | 855-864 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults | |
| P478 | volume | 187 |
| Q89554855 | A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease |
| Q64119526 | A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Challenge |
| Q48125700 | A milestone in the investigation of population-wide effects of vaccines. |
| Q94603399 | A pneumococcal controlled human infection model in Malawi: Transfer of an established pneumococcal carriage model from Liverpool, UK to Blantyre, Malawi - A feasibility study |
| Q41445924 | Absence of Streptococcus pneumoniae in pharyngeal swabs of geriatric inpatients |
| Q38255618 | Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic |
| Q37675714 | Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage |
| Q55491630 | Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging. |
| Q52715343 | Antibodies Reactive to Commensal Streptococcus mitis Show Cross-Reactivity With Virulent Streptococcus pneumoniae Serotypes. |
| Q41436543 | Antibody Response is More Likely to Pneumococcal Proteins Than to Polysaccharide After HIV-associated Invasive Pneumococcal Disease |
| Q37264678 | CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice |
| Q35806621 | Clinical and Microbiological Factors Associated with High Nasopharyngeal Pneumococcal Density in Patients with Pneumococcal Pneumonia |
| Q88068954 | Colonization-induced protection against invasive pneumococcal disease in mice is independent of CD103 driven adaptive immune responses |
| Q90340982 | Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation |
| Q27009175 | Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus |
| Q35635685 | Delayed reconstitution of B cell immunity to pneumococcus in HIV-infected Malawian children on antiretroviral therapy |
| Q34479487 | Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells |
| Q30279261 | Design, recruitment, and microbiological considerations in human challenge studies. |
| Q39123904 | Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece. |
| Q56378326 | Experimental infection of human volunteers |
| Q34794776 | Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children |
| Q38950882 | First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial |
| Q35855909 | Genetic stability of pneumococcal isolates during 35 days of human experimental carriage |
| Q56912161 | Identifying human encounters that shape the transmission of Streptococcus pneumoniae and other acute respiratory infections |
| Q38185814 | Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions |
| Q33734282 | Impact of experimental human pneumococcal carriage on nasopharyngeal bacterial densities in healthy adults |
| Q37086940 | Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults |
| Q58105793 | Inflammation induced by influenza virus impairs human innate immune control of pneumococcus |
| Q92285842 | Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization |
| Q91665960 | Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine |
| Q35113446 | Low prevalence of pneumococcal carriage and high serotype and genotype diversity among adults over 60 years of age living in Portugal |
| Q38984814 | Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization |
| Q64076710 | Mechanisms of Naturally Acquired Immunity to |
| Q91936430 | Microinvasion by Streptococcus pneumoniae induces epithelial innate immunity during colonisation at the human mucosal surface |
| Q36438285 | Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage |
| Q90471605 | Mouse IgG2a Antibodies Specific for the Commensal Streptococcus mitis Show Stronger Cross-Reactivity with Streptococcus pneumoniae than IgG1 Antibodies |
| Q55633626 | Nasopharyngeal Exposure to Streptococcus pneumoniae Induces Extended Age-Dependent Protection against Pulmonary Infection Mediated by Antibodies and CD138+ Cells. |
| Q38768647 | Nasopharyngeal colonization with Streptococcus pneumoniae triggers dendritic cell dependent antibody responses against invasive disease in mice |
| Q36263931 | Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens |
| Q37287225 | Neuraminidase A-Exposed Galactose Promotes Streptococcus pneumoniae Biofilm Formation during Colonization. |
| Q34078369 | Pathogen evolution and the immunological niche |
| Q38861144 | Pneumococcal Capsular Polysaccharide Immunity in the Elderly |
| Q36734938 | Pneumococcal Colonization Rates in Patients Admitted to a United Kingdom Hospital with Lower Respiratory Tract Infection: a Prospective Case-Control Study |
| Q90186763 | Pneumococcal colonisation is an asymptomatic event in healthy adults using an experimental human colonisation model |
| Q62487380 | Pneumococcal colonization in healthy adult research participants in the conjugate vaccine era, United Kingdom, 2010-2017 |
| Q49352945 | Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial |
| Q37559933 | Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage |
| Q41612508 | Promises and pitfalls of live attenuated pneumococcal vaccines |
| Q39147459 | Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection |
| Q35154329 | Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses |
| Q37309218 | Rationale and prospects for novel pneumococcal vaccines |
| Q58586401 | Role of Inflammatory Risk Factors in the Pathogenesis of |
| Q34196888 | Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection |
| Q92700350 | Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion |
| Q38177271 | Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design. |
| Q52337590 | Streptococcus pneumoniae: transmission, colonization and invasion. |
| Q89609370 | Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx |
| Q33627684 | The Alpha-Tocopherol Form of Vitamin E Boosts Elastase Activity of Human PMNs and Their Ability to Kill Streptococcus pneumoniae |
| Q89975815 | The Dynamics of Respiratory Microbiota during Mechanical Ventilation in Patients with Pneumonia |
| Q35068763 | The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition |
| Q104517897 | The histone demethylase KDM6B fine-tunes the host response to Streptococcus pneumoniae |
| Q28084920 | The host immune dynamics of pneumococcal colonization: implications for novel vaccine development |
| Q48364114 | The immunological mechanisms that control pneumococcal carriage. |
| Q91705453 | The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan |
| Q35224554 | Unveiling time in dose-response models to infer host susceptibility to pathogens. |
| Q35199001 | Update in sepsis and pulmonary infections 2013. |
| Q94545406 | Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives |
| Q40409110 | Were Antibody Titers the Right Parameter When Immunologically Comparing Pneumococcal Vaccines? |
Search more.